Spectral Diagnostics, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Toronto-based cardiac diagnostics company completes its offering of Special Convertible Securities. The offering will result in the issue of 1 mil. common shares of the stock and will net the firm $21.7 mil (at current exchange rates). First Marathon, Burns Fry, and Thomson Kernaghan are underwriting. Spectral plans to use the proceeds to fund its Point-of-Care line of cardiac diagnostics, which feature rapid format panel tests for diagnosing the cause of chest pain